YuhchyauChenMD

Clinical Trials

• Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2003 Jun 01

  Completed

  Phase 3

• Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Start of enrollment: 2005 Mar 01

  Completed

  Not Applicable

• Trial of Chemotherapy Followed by Pulsed Docetaxel and Concurrent Radiation for Non-Small Cell Lung Cancer Start of enrollment: 2002 Feb 01

  Completed

  Phase 2

• Genotoxicity Assessment for Patients Undergoing Radiation Treatment Start of enrollment: 2006 Apr 01

  Completed

• Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix Start of enrollment: 2005 Jan 01

  Completed

  Phase 2

• S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer Start of enrollment: 2006 Apr 01

  Terminated

  Phase 1

• Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Start of enrollment: 2006 Jul 01

  Completed

  Phase 3

• Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

  ACTIVE_NOT_RECRUITING

  PHASE3

• Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Start of enrollment: 2008 Mar 01

  Active, not recruiting

  Phase 3

• Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer Start of enrollment: 2009 Feb 01

  Completed

  Phase 1, Phase 2

• Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23

  Active, not recruiting

  Phase 3

• Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2009 Apr 15

  Completed

  Phase 3

• Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma

  ACTIVE_NOT_RECRUITING

  PHASE3

• Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma Start of enrollment: 2009 Jun 01

  Completed

  Phase 2

• Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation Start of enrollment: 2009 Dec 01

  Completed

  Phase 1

• Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2008 Mar 01

  Withdrawn

  Phase 2

• Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

  ACTIVE_NOT_RECRUITING

  PHASE3

• Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer Start of enrollment: 2009 Jun 29

  Active, not recruiting

  Phase 3

• RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2010 Mar 31

  Active, not recruiting

  Phase 3

• Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer Start of enrollment: 2011 Feb 01

  Completed

  Phase 2

• Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy

  ACTIVE_NOT_RECRUITING

  PHASE3

• Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05

  ACTIVE_NOT_RECRUITING

  PHASE3

• Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2010 Mar 01

  Completed

  Phase 2

• Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2010 Dec 01

  Completed

  Phase 1, Phase 2

• Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery Start of enrollment: 2010 Jun 01

  Completed

  Phase 2

• Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14

  Completed

  Phase 3

• Radiation Therapy with or Without Chemotherapy in Treating Patients with High-Risk Malignant Salivary Gland Tumors That Have Been Removed by Surgery

  ACTIVE_NOT_RECRUITING

  PHASE2

• Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas Start of enrollment: 2012 Feb 01

  Completed

  Phase 1

• Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer

  ACTIVE_NOT_RECRUITING

  PHASE3

• Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma Start of enrollment: 2011 Sep 01

  Completed

  Phase 2

• Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery Start of enrollment: 2011 Oct 01

  Completed

• Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer Start of enrollment: 2012 Dec 06

  Completed

  Phase 2

• Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma Start of enrollment: 2012 Dec 20

  Completed

  Phase 2

• A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck Start of enrollment: 2013 Aug 01

  Completed

  Phase 1

• Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) Start of enrollment: 2019 Jul 26

  ACTIVE_NOT_RECRUITING

  PHASE3

• Join now to see all